The PainChek Ltd (ASX: PCK) share price was among the few ASX shares that stayed in the green today, closing up 2.56% at 8 cents.
The share price increase came off the back of the company half-year report announced to the market yesterday. Let’s take a look.
Why did the Painchek share price rise today?
Shares in the small-cap rose as revenue jumped 40% to $2.08 million for the half-year ending 30 December 2020.
However, this does not fully represent how the company performed in the period. Looking deeper into the results, we can see that revenue from continuing operations fell 30% to $127,000. The majority of the group’s revenue was made up of research and development (R&D) and government grants.
As such, the company reported a net loss from operations for the half-year of $1.35 million.
PainChek continued to deliver sales growth in Australian residential aged care (RAC). Sales growth in the period resulted in total global licenses covering 71,318 beds, a 123% growth year on year (YoY). Furthermore, domestic sales reflected more than 30% of the Australian RAC.
Moreover, the company now has 884 aged care clients, growing 133% on the previous corresponding period. Forward-looking revenue equates to more than $3 million in annualised recurring revenue.
Looking ahead
PainChek aims to further develop its platform for use in new and larger healthcare market segments. The company said this was core to its business growth over the next 12 months.
In addition, the company has a number of products pending regulatory clearance. PainChek’s business strategy includes the release of an app for assessing pain in young children.
Having recently completed the app development and clinical validation work, the company is projecting Australian (TGA) and European (CE) mark regulatory clearances in the second quarter of the calendar year 2021.
Promisingly, its children’s app serves a potentially larger market than the adult app with a large hospital market and home care market opportunity.
Where to invest $1,000 right now
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.
*Returns as of February 15th 2021
More reading
- Here are 3 ASX 200 diamonds in the spotlight while the market sank today
- The Santos (ASX:STO) share price dips on stable credit rating
- Genworth Mortgage (ASX:GMA) share price slumps on $107 million loss
- Why the WhiteHawk (ASX:WHK) share price is crashing 8% lower
- Why the Immuron (ASX:IMC) share price fell today
Motley Fool contributor Daniel Ewing has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.
The post Why the Painchek (ASX:PCK) share price is edging higher today appeared first on The Motley Fool Australia.
from The Motley Fool Australia https://ift.tt/3bDEjkh
Leave a Reply